🔎 Trials Near Me

Home › Macular Degeneration › California

Macular Degeneration clinical trials in California

20 studies for Macular Degeneration are looking for participants at sites in California.

Cities in California

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Global Research Management, Inc., Glendale
  • Retinal Consultants Medical Group (Site 024), Modesto
  • Azul Vision / California Eye Specialists Medical Group, Inc., Pasadena
  • and 3 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Retina Consultants of Orange County, Fullerton
  • Shiley Eye Institute Jacobs Retina Center, La Jolla
  • California Retina Consultants, Oxnard
  • and 3 more
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148

A Study in Adults With Geographic Atrophy

  • California Retina Consultants, Bakersfield
  • Retina-Vitreous Associates Medical Group, Beverly Hills
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Retina Vitreous Associates Medical Group, Beverly Hills
  • Retina Specialists of Beverly Hills- Department of Ophthalmology, Beverly Hills
  • Eye Medical Center of Fresno, Fresno
  • and 19 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • California Retina Consultants, Bakersfield
  • Retina-Vitreous Associates Medical Group, Beverly Hills
  • Macula and Retina Institute, Glendale
  • and 4 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Jules Stein Eye Institute, Los Angeles
  • Stanford University Byers Eye Institute, Palo Alto
  • Kaiser Permanente Riverside Medical Center, Riverside
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Retina Consultants San Diego, Poway
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • Stanford University School of Medicine, Palo Alto
  • University of California Health - UC Davis, Sacramento
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • California Retina Consultants, Oxnard
  • Retinal Consultants Medical Group, Sacramento
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

  • Retina-Vitreous Associates Medical Group, Beverly Hills
  • Bay Area Retina Associates, Walnut Creek
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT06659549

Phase 1 Study of C.001 in Retinal Degeneration

  • Retina Vision Consultants, Beverly Hills
  • Palo Alto Medical Foundation, Palo Alto
  • Retinal Consultants Medical Group, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07594236

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • The Retina Partners, Encino
  • Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View
  • Orange County Retina Medical Group, Santa Ana
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

  • Adverum site 109, Bakersfield
  • Adverum site 169, Fullerton
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649

Effects of Goji vs. Fiber on Macular Degeneration

  • UC Davis Eye Center, Tschannen Eye Institute, Sacramento
RecruitingHealthy volunteers welcome
Ages 65 to 95 · All sexes · Updated Jul 17, 2026 · NCT06237127

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

  • Beverly Hills, CA, Beverly Hills
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 7, 2026 · NCT07587515

Village-Integrated Eye Worker Trial II

  • University of California, San Francisco, San Francisco
RecruitingHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Jun 9, 2026 · NCT03752840

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

  • University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 55 and older · All sexes · Updated Apr 29, 2026 · NCT07556406

Strategies for Improving Linkage-to-Care After Eye Disease Screening

  • University of California, San Francisco, San Francisco
Recruiting
Ages 60 and older · All sexes · Updated Apr 29, 2026 · NCT06943599

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Retinal Diagnostic Center, Campbell
  • Retina Consultants of Orange County, Fullerton
  • Northern California Retina Vitreous Associates, Mountain View
  • and 4 more
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Loma Linda University, Loma Linda
  • Eye Physicians of Long Beach, Long Beach
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.